📇 Rhumatologue · REIMS CEDEX · (51) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Centre hospitalier universitaire (CHU) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
32 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 1 fois dans les médias — pédagogie reconnue
Délais de RDV courts dans la région
134.8 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
64
64 articles ont été cités au moins 64fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
14 382
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
402
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
155
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Centre Hospitalier Universitaire de Reims · Université de Reims Champagne-Ardenne
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Neuroendocrine Tumors and Pregnancy: The French PregNET Study
2026ArticleEuropean Journal of Endocrinology
Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network
2026ArticleEndocrine Pathology
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease
2026ArticleDigestive and Liver Disease
Aorto-mesenteric space reduction in women with anorexia nervosa: retrospective audit and analysis
2026ArticleJournal of Eating Disorders
Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)
2026ArticleWorld Journal of Surgery
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study
2025ArticleDigestive and Liver Disease
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
2025ArticleAlimentary Pharmacology & Therapeutics
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission
2025ArticleClinical Gastroenterology and Hepatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
HOPITAL ROBERT DEBRE CHU REIMS
R DU GENERAL KOENIG, 51092 REIMS CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Revue Médicale Suisse · 11/03/2022
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQRjBVNFluV2ZWRkxkYlhObEV2b09oeTdYMGdTM2VORVNjYlZqanJxV3BzS0hmaDFoMFBLb3ZqN0hkangyZVRubzIyT2tDaUlPWi1FOFhIdmxuc19YSlJTTUhmYUVVY1BRX0hSSWRCWFdhaDRLTUtGdTJBVC1zLUpfZjdPREc2TC1VRndIZzhDWFAyMDJxRVN0Y2EzaDdUNFZrTXJyZ0I3R25nWjV1c0dsYnk3amFQN0dyUU
Alimentary pharmacology & therapeutics · 2020
SummaryBackgroundPhase III trials have demonstrated the efficacy and safety of ustekinumab in moderate‐to‐severe ulcerative colitis (UC), but few real‐world data are currently available.AimTo assess short‐term effectiveness and safety of ustekinumab in patients with UC.MethodsFrom January to September 2019, all patients with UC treated with ustekinumab in 20 French GETAID centres were retrospectively included. The primary outcome was steroid‐free clinical remission (partial Mayo Clinic score ≤2) at weeks 12‐16 without a rectal bleeding subscore >1.ResultsAmong the 103 patients included, 70% had been previously exposed to ≥2 anti‐TNF agents and 85% to vedolizumab. At weeks 12‐16, steroid‐free clinical remission and clinical remission rates were 35.0% and 39.8% respectively; the absence of rectal bleeding with normal stool frequency was noted in 19.4% of patients. Two patients discontinued ustekinumab before the week 12‐16 visit and underwent surgery. In multivariable analysis, a partial Mayo Clinic score >6 at inclusion (18.6% vs 46.7%, P = 0.003) and a history of both exposure to anti‐TNF and vedolizumab therapies (27.3% vs 80.0%, P = 0.001) were negatively associated with steroid‐free clinical remission at weeks 12‐16. Adverse events occurred in 7.8% of patients and serious adverse events in 3.9% of patients.ConclusionIn a cohort of highly refractory patients with UC with multiple prior drug failures, ustekinumab provided steroid‐free clinical remission in one‐third of cases at weeks 12‐16. Clinical severity and previous use of anti‐TNF and vedolizumab therapies were associated with ustekinumab failure at weeks 12‐16.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Endocrine pathology · 2026 · Journal Article
Hunaut T, Gérard L, Hercent A, Hentic O, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026 · Journal Article
Fontaine L, Seksik P, Stefanescu C, Nachury M, et al.
Journal of clinical medicine · 2025 · Journal Article
Beissat M, Geoffroy M, Bolko L, Hittinger A, et al.
Gastro hep advances · 2024 · Journal Article
Hunaut T, Peyrin-Biroulet L, Le Bozec A, Germain A, et al.
Journal of Crohn's & colitis · 2024 · Journal Article
Muller M, Broséus J, Guilloteau A, Wasse S, et al.
European journal of endocrinology · 2023 · Journal Article
Perrier M, Brugel M, Gérard L, Goichot B, et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023 · Journal Article
De Rycke O, Perrier M, Ouvrard É, Mennetrey C, et al.
Medicine · 2022 · Journal Article
Morland D, Triumbari EKA, Hoog C, Sézin G, et al.
Endocrine · 2022 · Journal Article
Lelièvre M, Triumbari EKA, Brixi H, Perrier M, et al.
Inflammatory bowel diseases · 2022 · Journal Article
Marion L, Amélie B, Zoubir D, Guillaume C, et al.
Clinical nuclear medicine · 2022 · Journal Article
Morland D, Jallet L, Deguelte S, Cadiot G, et al.
Clinical nuclear medicine · 2022 · Journal Article
Morland D, Jallerat P, Brixi H, Cadiot G, et al.
Diagnostic and interventional imaging · 2021 · Journal Article
Djelouah M, Marical V, Kanagaratnam L, Kianmanesh R, et al.
European journal of cancer (Oxford, England : 1990) · 2021 · Journal Article
Hadoux J, Kanaan C, Durand A, Hescot S, et al.
Endocrine-related cancer · 2021 · Journal Article
de Mestier L, Lamarca A, Hernando J, Zandee W, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2021 · Case Reports
Perrier M, Delemer B, Deguelte S, Legros V, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020 · Letter
Perrier M, Hentic O, Walter T, Do Cao C, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020 · Journal Article
Lambin T, Amiot A, Stefanescu C, Gornet JM, et al.
PLoS medicine · 2020 · Journal Article
Hässler S, Bachelet D, Duhaze J, Szely N, et al.
Journal of clinical medicine · 2020 · Journal Article
Deguelte S, Perrier M, Hammoutene C, Cadiot G, et al.
Annales de pathologie · 2020 · Case Reports
Beaudoux O, Cadiot G, Marchal A
World journal of surgery · 2026 · Journal Article
Gaujoux S, Pattou F, Cadiot G, Adham M, et al.
The Lancet. Oncology · 2023 · Journal Article
Nesti C, Bräutigam K, Benavent M, Bernal L, et al.
Alimentary pharmacology & therapeutics · 2021 · Journal Article
Broussard D, Rivière P, Bonnet J, Fotsing G, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025 · Journal Article
Mathieu N, Hupé M, Heluwaert F, Rivière P, et al.
Pharmaceutics · 2021 · Journal Article
Konecki C, Feliu C, Cazaubon Y, Giusti D, et al.
Scandinavian journal of gastroenterology · 2022 · Multicenter Study
Meyer A, Fumery M, Peyrin-Biroulet L, Filippi J, et al.
Alimentary pharmacology & therapeutics · 2020 · Journal Article
Amiot A, Filippi J, Abitbol V, Cadiot G, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026 · Journal Article
Gendard M, Seksik P, Stefanescu C, Meyer A, et al.
Alimentary pharmacology & therapeutics · 2025 · Journal Article
Osty M, Altwegg R, Serrero M, Benezech A, et al.
Aorto-mesenteric space reduction in women with anorexia nervosa: retrospective audit and analysis
Abstract Background and aims Superior mesenteric artery syndrome (SMAS) is a rare condition favored by weight loss, with nonspecific digestive complaints that may hinder weight recovery in anorexia nervosa. This study ai
Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study
<strong>Article full text</strong> <br><br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text on
Evaluation of Nurses’ and Patients’ Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study
<strong>Article full text</strong> <br><br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text on
Aorto-mesenteric space reduction in women with anorexia nervosa: retrospective audit and analysis
Abstract Background and aims Superior mesenteric artery syndrome (SMAS) is a rare condition favored by weight loss, with nonspecific digestive complaints that may hinder weight recovery in anorexia nervosa. This study ai
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Annals of surgery · 2020 · Journal Article
Vinault S, Mariet AS, Le Bras M, Mirallié E, et al.
Journal of Crohn's & colitis · 2020 · Case Reports
Condamina M, Diaz E, Jamart C, Loget J, et al.